Clinical Trial Update: Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of fixed-dose once-daily oral aripiprazole in children and adolescents with Tourette syndrome and tic disorders…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tic Disorders
• Tourette Syndrome

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Tourette's Disorder, Tic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-02-13